Intelligence Β· Clinical Development
Pipeline search results
Programs matching βradiationβ across our ClinicalTrials.gov index β phase, modality, sponsor, and trial IDs.
Quick answer
Showing 59 pipeline programs matching "radiation" from NovaPharmaNews Clinical Development Intelligence β phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Hypofractionated radiation/chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer
1 trial -
Low Dose GC4419: 30mg/day
Galera Therapeutics
Radiation Induced Oral Mucositis
1 trial -
Memantine Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Disease
1 trial -
Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Oral Mucositis
1 trial -
Radiation+PD-1 Ab
The First People's Hospital of Lianyungang
Proton Therapy
1 trial -
Radiation: 131I-MIBG
United Therapeutics Europe Ltd
Neuroblastoma
1 trial -
Radiation: Proton Therapy+PD-1 Ab
The First People's Hospital of Lianyungang
Proton Therapy
1 trial -
Radiation: Radiation TherapyοΌBiological: Personalized tumor peptide vaccine
Hospital Authority, Hong Kong
Advanced Tumors
1 trial -
SBRT combined with PD-1 inhibitors and thoracic hyperthermia
The First People's Hospital of Lianyungang
Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
1 trial -
SPLFIO-174
The George Institute
Non-small cell lung cancer (NSCLC): - Locally advanced NSCLC where participants are not candidates for surgical resection and/or definitive chemoradiation, or - Metastatic NSCLC
1 trial -
Spermidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Xerostomia
1 trial -
Spray of spirulina derivatives
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-induced Oral Mucositis
1 trial -
Tetrahydrobiopterin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Enteritis
1 trial -
irradiation
Ultragenyx UK Limited
Brain Neoplasms
1 trial -
radiation therapy
Children's Hospital of Fudan University
Brain Tumor
1 trial -
3-dimensional conformal radiation therapy
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
Aflibercept every 2 months
Regeneron UK Limited
Radiation Retinopathy
1 trial -
BIO 300 Oral Powder
United Therapeutics Europe Ltd
Acute Radiation Syndrome
1 trial -
QL0911-102
Lacuna Pharma Pty Ltd
Immune Thrombocytopenia, Hematopoietic Syndrome of Acute Radiation Syndrome
1 trial -
Radiation: 18F-AlF-FAPi-04
Sichuan Provincial People's Hospital
Tumor, Solid
1 trial -
Tetrahydrobiopterin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation-Induced Dermatitis
1 trial -
GTM-103
GT Biopharma
Glioblastoma
1 trial -
Stereotactic Radiation Therapy
GT Biopharma
Glioblastoma
1 trial -
Accelerated partial breast irradiation
Universal Integrated
Breast Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs β not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars β improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes β use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.